Dr. Alousi is Professor of Medicine in the Department of Stem Cell Transplant and Cellular Therapy at the University of Texas, MD Anderson Cancer Center where he serves as the Inpatient Medical Director as well as the Director of the Multi-Discipline Graft-vs.-Host Disease (GVHD) Clinic and Research Program. His area of research is in the prevention and treatment of acute and chronic GVHD as well as survivorship needs in recipients of allogeneic hematopoietic cell transplantation. He has served as principle investigator of numerous single-center and multi-center trials investigating novel therapies in the prevention and treatment of GVHD. He is the prior co-chair for the Center for International Blood and Marrow Research GVHD Study Section in addition to serving on the Blood and Marrow Transplant Clinical Trials Networks GVHD State of the Science Committee, National Institute of Health’s 2021 Chronic GVHD Consensus Panel, Chronic GVHD Consortium Data Safety Board and the FDA’s Acute GVHD Clinical Trials Endpoint Conference.